Literature DB >> 15225881

Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.

Anne Terry1, Anna Kilbey, François Vaillant, Monica Stewart, Alma Jenkins, Ewan Cameron, James C Neil.   

Abstract

The Runx2 (Cbfa1, Aml3, PEBP2alphaA) gene plays an essential role in bone development and is one of a three-member family of closely related genes that encode the alpha-chain DNA binding components of the heterodimeric core binding factor complex. While all three mammalian Runx genes share a complex dual promoter structure (P1, P2) and display alternative splicing, a distinctive feature of Runx2 is the potential to encode larger isoforms in which the C-terminal domain encoded by the standard 3' terminal exon (exon 6) is replaced by an extended 200-201 amino acid C-terminal sequence including an extensive proline-rich domain and a C-terminal amphipathic helix. We report that the novel exon that gives rise to these variants (exon 6.1) is located over 100 kb downstream of exon 6 in the mouse, rat and human genomes. Exon 6.1 spans a CpG-rich island, and human/rodent conservation is evident through the coding sequence and the 3' untranslated region (UTR). Reverse transcriptase polymerase chain reaction (RT-PCR) and blot hybridisation analyses reveal that exon 6.1 is utilised at low levels in all mouse tissues and cell lines that express Runx2, regardless of which promoter is active, giving Runx2 the potential to encode more than 12 distinct isoforms. RT-PCR analysis of human RUNX2 exon 6.1 expression shows that utilisation of this exon is also conserved. In vitro transcription/translation of cDNAs encoding several exon 6.1 isoforms reveals that the novel Runx proteins are able to bind specifically to canonical Runx DNA target sequences. Antibodies raised to the unique C-terminal domain were shown to be reactive by immunoprecipitation and immunoblot assay, and were used in confocal immunofluorescence microscopy to reveal low level cytoplasmic staining in osteosarcoma and lymphoma cells that express high levels of Runx2 mRNA. However, reactive protein could not be detected in immunoblots of extracts from either cell type, suggesting that these proteins are unstable in lymphoid and osteosarcoma cells. In conclusion, the conservation and widespread utilisation of Runx2 exon 6.1 suggest that its encoded isoforms play an as yet undetermined role in mammalian development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225881     DOI: 10.1016/j.gene.2004.04.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.

Authors:  Jane Y Dancer; Stephen P Henry; Jolanta Bondaruk; Sangkyou Lee; Alberto G Ayala; Benoit de Crombrugghe; Bogdan Czerniak
Journal:  Hum Pathol       Date:  2010-12       Impact factor: 3.466

2.  Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.

Authors:  Andre L P Tavares; Jessie A Brown; Emily C Ulrich; Katerina Dvorak; Raymond B Runyan
Journal:  Dev Dyn       Date:  2017-07-19       Impact factor: 3.780

3.  Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation.

Authors:  Julie C Liu; Christopher J Lengner; Tripti Gaur; Yang Lou; Sadiq Hussain; Marci D Jones; Brent Borodic; Jennifer L Colby; Heather A Steinman; Andre J van Wijnen; Janet L Stein; Stephen N Jones; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

4.  Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.

Authors:  S Wotton; A Terry; A Kilbey; A Jenkins; P Herzyk; E Cameron; J C Neil
Journal:  Oncogene       Date:  2008-06-16       Impact factor: 9.867

5.  Differential parental transmission of markers in RUNX2 among cleft case-parent trios from four populations.

Authors:  Jae Woong Sull; Kung-Yee Liang; Jacqueline B Hetmanski; Margaret Daniele Fallin; Roxann G Ingersoll; Jiwan Park; Yah-Huei Wu-Chou; Philip K Chen; Samuel S Chong; Felicia Cheah; Vincent Yeow; Beyoung Yun Park; Sun Ha Jee; Ethylin Wang Jabs; Richard Redett; Euiju Jung; Ingo Ruczinski; Alan F Scott; Terri H Beaty
Journal:  Genet Epidemiol       Date:  2008-09       Impact factor: 2.135

Review 6.  Post-translational Regulation of Runx2 in Bone and Cartilage.

Authors:  J H Jonason; G Xiao; M Zhang; L Xing; D Chen
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

7.  Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain.

Authors:  Jae-Hwan Jeong; Jung-Sook Jin; Hyun-Nam Kim; Sang-Min Kang; Julie C Liu; Christopher J Lengner; Florian Otto; Stefan Mundlos; Janet L Stein; Andre J van Wijnen; Jane B Lian; Gary S Stein; Je-Yong Choi
Journal:  J Cell Physiol       Date:  2008-11       Impact factor: 6.384

8.  The Role of RUNX2 in Osteosarcoma Oncogenesis.

Authors:  J W Martin; M Zielenska; G S Stein; A J van Wijnen; J A Squire
Journal:  Sarcoma       Date:  2010-12-09

9.  Runx family genes in a cartilaginous fish, the elephant shark (Callorhinchus milii).

Authors:  Giselle Sek Suan Nah; Zhi Wei Lim; Boon-Hui Tay; Motomi Osato; Byrappa Venkatesh
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.

Authors:  Jeffrey W Martin; Susan Chilton-MacNeill; Madhuri Koti; Andre J van Wijnen; Jeremy A Squire; Maria Zielenska
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.